BIOTECH: Inks $670M Deal to Bolster Pipeline
Lineage Cell Therapeutics is rapidly expanding its cell therapy pipeline. In late March, the company announced a new investigational product candidate – an auditory neuronal cell transplant for the treatment of hearing loss, with an initial focus on the treatment of auditory neuropathy spectrum disorders.
LIFE SCIENCES: New Headquarters in Carmel Valley
In what has been billed as one of the biggest life science leases ever for the San Diego County market, Neurocrine Biosciences has leased 535,000 square feet of space in a Carmel Valley campus that is still under construction. The location will become the company’s new corporate headquarters.
REAL ESTATE: NorCal Firm Establishing SD Footprint
A bio-tech company based in Northern California is establishing a San Diego footprint in Torrey Pines with plans to grow aggressively over the next year.
BIOTECH: Deal Boosts Growth, Revenue
In a deal showcasing Halozyme Therapeutics as an ongoing leader in drug delivery, the San Diego-based biotech announced earlier this month (April 13) it had entered into a definitive agreement to acquire New Jersey-based Antares Pharma for $5.60 a share.
HEALTHCARE: Round to Fuel Fast-Growing Virtual Diabetes Clinic
San Diego-based 9am.health, a fast-growing virtual diabetes clinic that delivers personalized care directly to consumers, has closed a $16 million Series A funding round, bringing its total funding to date to nearly $20 million.
HEALTHCARE: Dr. Kami Hoss Wants to Revolutionize Dentistry
Local orthodontist and dentofacial orthopedist Dr. Kami Hoss wants to reinvent the dental patient care paradigm – especially as it pertains to the youngest patients.
TELEHEALTH: Latest Funding Round Led by Cobalt Ventures
San Diego telehealth company ArtistaMD is expanding its eConsult (electronic consulting) platform, thanks to a funding round by Cobalt Ventures, a subsidiary of Blue Cross and Blue Shield of Kansas City.
San Diego-based Halozyme Therapeutics announced Wednesday plans to acquire New Jersey-based Antares Pharma for $5.60 a share. The all-cash deal is valued at around $960 million.
HEALTHCARE: Calculating Heart Attack Risk
Understanding your genetic risk of coronary artery disease (CAD) artery disease will more likely push you to seek out preventative treatment. That is the conclusion of a study by a Scripps Research team that developed a smartphone app that can calculate a users’ genetic risk for CAD.
Entrepreneur and philanthropist Jennifer Rubio has been named to the board of directors at Scripps Research.
ARCHITECTURE: Medical Projects Are His Specialty
San Diego architect Ray Fox is the man medical professionals from across the country turn to when they need someone to design a new office or transform a tired old building into a model of modern medicine.
BIOTECH: Highlights Include Strong IPO, Launch of G4 Sequencer
Six years ago, investor Andrew Spaventa and former Illumina CSO David Barker decided to invest in Eli Glezer’s idea to start a company that would develop new technologies that would have an impact in biological research and medicine.
Palomar Health is making an effort to meet medical needs in Ukraine. The organization plans to send medical supplies to the country as well as medical staff once it is safe to do so.
ARCHITECTURE: Project is Revolutionary in Design, Patient Treatment
Ware Malcomb has designed a ground-breaking cerebral palsy clinic at Rady Children’s Hospital that incorporates revolutionary technology and designs.
BIOTECH: CE Mark for G7 Device OK’d
Dexcom and its tech driven continuous glucose monitoring systems (CGM) continue to impress around the world. On March 14, the San Diego-based company’s next-generation CGM, the G7, was granted a CE mark from the European Union.